ARCHIVES

The Cancer Letter takes summer publication break, back Sept. 12.

This article is from The Cancer Letter archive.

Vol. 29 No. 32 | August 8, 2003

Download PDF Visit The Full Archive

Related Articles

‘We Cannot Tolerate One Third Reduction In Centers. Prevention, Clinical Trials Programs’

September 20, 1991

FDA Ponders Standards For “Retrospective Prospective” Studies

January 30, 2009

Breast Cancer Rates Decline Most for Affluent White Women

February 26, 2010

NIH Slow To Implement Equality In Studies, GAO Says, But Waxman Assures Reauthorization

June 22, 1990

Lilly Made False Claims About Ralozifene Reducing Breast Cancer risk, Judge Rules

July 30, 1999

FDA Adopts Final Diagnostics X-Ray Rule Amendment

September 9, 1977